Correlation Between Biomarin Pharmaceutical and Ideaya Biosciences
Can any of the company-specific risk be diversified away by investing in both Biomarin Pharmaceutical and Ideaya Biosciences at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Biomarin Pharmaceutical and Ideaya Biosciences into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Biomarin Pharmaceutical and Ideaya Biosciences, you can compare the effects of market volatilities on Biomarin Pharmaceutical and Ideaya Biosciences and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Biomarin Pharmaceutical with a short position of Ideaya Biosciences. Check out your portfolio center. Please also check ongoing floating volatility patterns of Biomarin Pharmaceutical and Ideaya Biosciences.
Diversification Opportunities for Biomarin Pharmaceutical and Ideaya Biosciences
0.92 | Correlation Coefficient |
Almost no diversification
The 3 months correlation between Biomarin and Ideaya is 0.92. Overlapping area represents the amount of risk that can be diversified away by holding Biomarin Pharmaceutical and Ideaya Biosciences in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Ideaya Biosciences and Biomarin Pharmaceutical is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Biomarin Pharmaceutical are associated (or correlated) with Ideaya Biosciences. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Ideaya Biosciences has no effect on the direction of Biomarin Pharmaceutical i.e., Biomarin Pharmaceutical and Ideaya Biosciences go up and down completely randomly.
Pair Corralation between Biomarin Pharmaceutical and Ideaya Biosciences
Given the investment horizon of 90 days Biomarin Pharmaceutical is expected to under-perform the Ideaya Biosciences. But the stock apears to be less risky and, when comparing its historical volatility, Biomarin Pharmaceutical is 2.17 times less risky than Ideaya Biosciences. The stock trades about -0.28 of its potential returns per unit of risk. The Ideaya Biosciences is currently generating about -0.12 of returns per unit of risk over similar time horizon. If you would invest 2,950 in Ideaya Biosciences on August 24, 2024 and sell it today you would lose (290.00) from holding Ideaya Biosciences or give up 9.83% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Very Strong |
Accuracy | 100.0% |
Values | Daily Returns |
Biomarin Pharmaceutical vs. Ideaya Biosciences
Performance |
Timeline |
Biomarin Pharmaceutical |
Ideaya Biosciences |
Biomarin Pharmaceutical and Ideaya Biosciences Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Biomarin Pharmaceutical and Ideaya Biosciences
The main advantage of trading using opposite Biomarin Pharmaceutical and Ideaya Biosciences positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Biomarin Pharmaceutical position performs unexpectedly, Ideaya Biosciences can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Ideaya Biosciences will offset losses from the drop in Ideaya Biosciences' long position.Biomarin Pharmaceutical vs. Alnylam Pharmaceuticals | Biomarin Pharmaceutical vs. Exelixis | Biomarin Pharmaceutical vs. Halozyme Therapeutics | Biomarin Pharmaceutical vs. Arrowhead Pharmaceuticals |
Ideaya Biosciences vs. AnaptysBio | Ideaya Biosciences vs. MeiraGTx Holdings PLC | Ideaya Biosciences vs. Keros Therapeutics | Ideaya Biosciences vs. Ventyx Biosciences |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Volatility module to check portfolio volatility and analyze historical return density to properly model market risk.
Other Complementary Tools
Fundamental Analysis View fundamental data based on most recent published financial statements | |
Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
Share Portfolio Track or share privately all of your investments from the convenience of any device |